It should be noted that recent studies have found that NKG2D can enhance NK cell-mediated ADCC in a synergistic manner, which can increase the anti-tumor activity of CAR-NK and serve as a complement to the way CAR kills solid tumor [67]. This evidence concerns the gene KLRK1 and neoplasm.